A ‘loophole’ in our insurance system was brought into the spotlight when a cancer patient ended up with a $33,000 bill after her insurer refused to pay for drugs used in her treatment. Can we avoid such instances from happening? Eddy Cheong, Head of Solutions, Providend shares his views.